Events & Presentations Presentation VAX-31 Phase 1/2 Adult Study Results Vaxcyte September Investor Presentation Vaxcyte VAX-24 Phase 2 65+ Adult Study Results VAX-24 Phase 1/2 Proof-of-Concept Study Topline Results Past Events Sep 3, 2024 8:00 AM EDT Vaxcyte VAX-31 Phase 1/2 Adult Study Results Conference Call Jun 5, 2024 11:30 AM EDT Jefferies Global Healthcare Conference May 14, 2024 12:20 PM EDT Bank of America Securities Health Care Conference Apr 9, 2024 12:45 PM EDT 23rd Annual Needham Virtual Healthcare Conference Mar 12, 2024 8:40 AM EDT Leerink Global Biopharma Conference Mar 5, 2024 2:10 PM EST Cowen 44th Annual Health Care Conference Apr 17, 2023 7:30 AM EDT Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Conference Call Feb 27, 2023 4:30 PM EST Vaxcyte Q4 2022 YE Earnings Conference Call Oct 24, 2022 8:00 AM EDT Vaxcyte VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call Jun 1, 2022 11:30 AM EDT Vaxcyte, Inc. Virtual Stockholders Meeting
Presentation VAX-31 Phase 1/2 Adult Study Results Vaxcyte September Investor Presentation Vaxcyte VAX-24 Phase 2 65+ Adult Study Results VAX-24 Phase 1/2 Proof-of-Concept Study Topline Results Past Events Sep 3, 2024 8:00 AM EDT Vaxcyte VAX-31 Phase 1/2 Adult Study Results Conference Call Jun 5, 2024 11:30 AM EDT Jefferies Global Healthcare Conference May 14, 2024 12:20 PM EDT Bank of America Securities Health Care Conference Apr 9, 2024 12:45 PM EDT 23rd Annual Needham Virtual Healthcare Conference Mar 12, 2024 8:40 AM EDT Leerink Global Biopharma Conference Mar 5, 2024 2:10 PM EST Cowen 44th Annual Health Care Conference Apr 17, 2023 7:30 AM EDT Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Conference Call Feb 27, 2023 4:30 PM EST Vaxcyte Q4 2022 YE Earnings Conference Call Oct 24, 2022 8:00 AM EDT Vaxcyte VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call Jun 1, 2022 11:30 AM EDT Vaxcyte, Inc. Virtual Stockholders Meeting